● Recruiting

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Condition: Glaucoma · Sponsor: Glaukos Corporation

PhasePhase 2/Phase 3

Planned participants610

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 949-739-8749 · ClinicalResearch@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (3)

Glaukos Investigative Site	Grand Junction, Colorado, United States	Recruiting
Glaukos Investigative Site	Oklahoma City, Oklahoma, United States	Recruiting
Glaukos Clinical Site	El Paso, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07075718